Edition:
India

Ovid Therapeutics Inc (OVID.OQ)

OVID.OQ on NASDAQ Stock Exchange Global Select Market

11.21USD
22 Nov 2017
Change (% chg)

$1.47 (+15.09%)
Prev Close
$9.74
Open
$9.80
Day's High
$11.45
Day's Low
$9.80
Volume
24,442
Avg. Vol
16,103
52-wk High
$15.70
52-wk Low
$5.28

Select another date:

Fri, Nov 10 2017

BRIEF-Ovid Therapeutics Q3 loss per share $0.38

* Ovid Therapeutics reports third quarter 2017 financial results and corporate progress

BRIEF-Ovid Therapeutics announces first patient randomized in phase 1b/2a clinical trial of TAK-935

* Ovid Therapeutics announces first patient randomized in phase 1b/2a clinical trial of TAK-935/OV935 in adults with rare epilepsies Source text for Eikon: Further company coverage:

BRIEF-Ovid Therapeutics Q2 loss per share $0.57

* Ovid Therapeutics reports second quarter 2017 financial results and corporate progress

Select another date: